Community-Led Monitoring AP Database AP Data Dashboard
WHO Technical Update: Transition to New Antiretrovirals in HIV Programmes - Clinical and Programmatic Considerations
Publications
July 31, 2017

WHO Technical Update: Transition to New Antiretrovirals in HIV Programmes - Clinical and Programmatic Considerations

This technical update summarizes the recent evidence and provides programme considerations to support countries on how to transition to new antiretroviral (ARV) drugs for use in first- and second-line ARV in low and middle- income countries.

Download PDF

As of June 2017, more than 20 low- and middle-income countries have included or are planning to include dolutegravir (DTG) as a first-line option in their national guidelines. This technical update summarizes the recent evidence and provides programme considerations to support countries on how to transition to new antiretroviral (ARV) drugs for use in first- and second-line ARV in low and middle- income countries.

Organizations:

World Health Organization (WHO)

Share article:

Related Resources